ROR1 and cancer: Thus, our result documenting a potent antitumor effect of PTK7-CAR T cells adds PTK7 to the kind list of ROR1, which, as a member of Wnt signaling-related pseudokinases, had a characteristic enriched expression in TIC/CSCs and is suitable as a potential therapeutic target for cancer immunotherapy.